These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2223062)

  • 1. Sialophorin (CD43) and the Wiskott-Aldrich syndrome.
    Remold-O'Donnell E; Rosen FS
    Immunodefic Rev; 1990; 2(2):151-74. PubMed ID: 2223062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome.
    Shelley CS; Remold-O'Donnell E; Davis AE; Bruns GA; Rosen FS; Carroll MC; Whitehead AS
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2819-23. PubMed ID: 2784859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome.
    Park JK; Rosenstein YJ; Remold-O'Donnell E; Bierer BE; Rosen FS; Burakoff SJ
    Nature; 1991 Apr; 350(6320):706-9. PubMed ID: 2023632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1.
    Rosenstein Y; Park JK; Hahn WC; Rosen FS; Bierer BE; Burakoff SJ
    Nature; 1991 Nov; 354(6350):233-5. PubMed ID: 1683685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD43 (leukosialin, sialophorin, large sialoglycoprotein) can be expressed in both normal and Wiskott-Aldrich fibroblasts via transfection of a leukosialin cDNA.
    Pallant A; Fukuda M; Frelinger JG
    Eur J Immunol; 1990 Jul; 20(7):1423-8. PubMed ID: 2143724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation.
    Mentzer SJ; Remold-O'Donnell E; Crimmins MA; Bierer BE; Rosen FS; Burakoff SJ
    J Exp Med; 1987 May; 165(5):1383-92. PubMed ID: 3572301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome.
    Piller F; Le Deist F; Weinberg KI; Parkman R; Fukuda M
    J Exp Med; 1991 Jun; 173(6):1501-10. PubMed ID: 2033371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich syndrome.
    Remold-O'Donnell E; Zimmerman C; Kenney D; Rosen FS
    Blood; 1987 Jul; 70(1):104-9. PubMed ID: 2439146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wiskott-Aldrich syndrome: report of an autosomal dominant variant.
    Rocca B; Bellacosa A; De Cristofaro R; Neri G; Della Ventura M; Maggiano N; Rumi C; Landolfi R
    Blood; 1996 Jun; 87(11):4538-43. PubMed ID: 8639821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of sialophorin (CD43)-expressing cells in experimental Staphylococcus aureus infection.
    Bremell T; Holmdahl R; Tarkowski A
    Infect Immun; 1994 Oct; 62(10):4637-40. PubMed ID: 7927732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective impairment of CD43-mediated T cell activation in the Wiskott-Aldrich syndrome.
    Siminovitch KA; Greer WL; Axelsson B; Rubin LA; Novogrodsky A; Peacocke M
    Immunodeficiency; 1993; 4(1-4):99-108. PubMed ID: 8167744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration of an integral membrane protein, CD43 (leukosialin, sialophorin), in the cleavage furrow through the interaction of its cytoplasmic domain with actin-based cytoskeletons.
    Yonemura S; Nagafuchi A; Sato N; Tsukita S
    J Cell Biol; 1993 Jan; 120(2):437-49. PubMed ID: 8421057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD43 is expressed normally on Wiskott-Aldrich-derived lymphocytes.
    Dragone L; Pallant A; Insel R; Frelinger JG
    Exp Clin Immunogenet; 1992; 9(3):130-40. PubMed ID: 1338889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of platelet calpain on normal T-lymphocyte CD43: hypothesis of events in the Wiskott-Aldrich syndrome.
    Remold-O'Donnell E; Van Brocklyn J; Kenney DM
    Blood; 1992 Apr; 79(7):1754-62. PubMed ID: 1558970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic fragmentation of sialophorin (CD43). Localization of the activation-inducing site and examination of the role of sialic acid.
    Remold-O'Donnell E; Rosen FS
    J Immunol; 1990 Nov; 145(10):3372-8. PubMed ID: 2230123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a CD43/leukosialin-mediated pathway for inducing apoptosis in human T-lymphoblastoid cells.
    Brown TJ; Shuford WW; Wang WC; Nadler SG; Bailey TS; Marquardt H; Mittler RS
    J Biol Chem; 1996 Nov; 271(44):27686-95. PubMed ID: 8910360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line.
    Lefebvre JC; Giordanengo V; Limouse M; Doglio A; Cucchiarini M; Monpoux F; Mariani R; Peyron JF
    J Exp Med; 1994 Nov; 180(5):1609-17. PubMed ID: 7964449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two sisters with clinical diagnosis of Wiskott-Aldrich syndrome: is the condition in the family autosomal recessive?
    Kondoh T; Hayashi K; Matsumoto T; Yoshimoto M; Morio T; Yata J; Tsuji Y
    Am J Med Genet; 1995 Oct; 60(5):364-9. PubMed ID: 8546147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction via leukocyte antigen CD43 (sialophorin). Feedback regulation by protein kinase C.
    Wong RC; Remold-O'Donnell E; Vercelli D; Sancho J; Terhorst C; Rosen F; Geha R; Chatila T
    J Immunol; 1990 Feb; 144(4):1455-60. PubMed ID: 2137493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16.
    Pallant A; Eskenazi A; Mattei MG; Fournier RE; Carlsson SR; Fukuda M; Frelinger JG
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1328-32. PubMed ID: 2521952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.